Jin Long Miao

Director/Miembro de la Junta en Jumpcan Pharmaceutical Co. Ltd. .

65 años

Health Technology

Perfil

Jin Long Miao is currently a Member-Supervisory Board & Manager at Jumpcan Pharmaceutical Co. Ltd.
Previously, he worked as a Member-Supervisory Board at Hubei Jumpcan Pharmaceutical Co., Ltd.

Cargos activos de Jin Long Miao

Empresas	Cargo	Inicio
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Director/Miembro de la Junta	-

Todos los cargos activos de Jin Long Miao

Antiguos cargos conocidos de Jin Long Miao.

Empresas	Cargo	Fin
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Director/Miembro de la Junta	20/04/2019

Ver el detalle de la experiencia de Jin Long Miao.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jin Long Miao.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Health Technology